BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.
BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.
Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 - an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the lab.
The ability to consistently bring treatments and cures to market depends upon a company’s capacity to create and sustain a successful product development pipeline.
Written for and originally published on AGT Big Picture Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing […]
With years of experience and expertise with pipettes, Gustavo Chavarria outlines pipetting factors and practices that lead to success and […]
These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in trials for […]